Surprisingly, during PCR amplification of NMUR2 from the human ovarian cancer cDNA, we identified a dominant splice variant that lacked the third exon, which we have named NMUR2S. Consequently, the encoded sequence is predicted to give rise to a six-transmembrane protein. This evidence concerns the gene NMUR2 and ovarian cancer.